Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
35.87
+0.60 (1.70%)
At close: Jun 27, 2025, 4:00 PM
36.30
+0.43 (1.20%)
After-hours: Jun 27, 2025, 7:43 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $20.17 billion as of June 27, 2025. Its market cap has increased by 62.86% in one year.
Market Cap
20.17B
Enterprise Value
26.69B
1-Year Change
62.86%
Ranking
Category
Stock Price
$35.87
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $20.17B, an increase of 27.96%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 14.86B | 31.12% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |